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Background: Colorectal cancer (CRC) is a leading cause of death worldwide. Chronic gut inﬂammation is
recognized as a risk factor for tumor development, including CRC. American ginseng is a very commonly
used ginseng species in the West.
Methods: A genetically engineered ApcMin/þ mouse model was used in this study. We analyzed the
saponin composition of American ginseng used in this project, and evaluated its effects on the pro-
gression of high-fat-diet-enhanced CRC carcinogenesis.
Results: After oral ginseng administration (10e20 mg/kg/d for up to 32 wk), experimental data showed
that, compared with the untreated mice, ginseng very signiﬁcantly reduced tumor initiation and pro-
gression in both the small intestine (including the proximal end, middle end, and distal end) and the
colon (all p < 0.01). This tumor number reduction was more obvious in those mice treated with a low
dose of ginseng. The tumor multiplicity data were supported by body weight changes and gut tissue
histology examinations. In addition, quantitative real-time polymerase chain reaction analysis showed
that compared with the untreated group, ginseng very signiﬁcantly reduced the gene expression of
inﬂammatory cytokines, including interleukin-1a (IL-1a), IL-1b, IL-6, tumor necrosis factor-a,
granulocyte-colony stimulating factor, and granulocyte-macrophage colony-stimulating factor in both
the small intestine and the colon (all p < 0.01).
Conclusion: Further studies are needed to link our observed effects to the actions of the gut microbiome
in converting the parent ginsenosides to bioactive ginseng metabolites. Our data suggest that American
ginseng may have potential value in CRC chemoprevention.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
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prevention.
Using Asian ginseng, a caseecontrol study on over a thousand
participants in Korea showed that participants who consumed
ginseng had a decreased risk of many different cancers compared
with those who did not. In addition, ginseng has a nonorgan-
speciﬁc cancer prevention effect [4,5]. In contrast to Asian
ginseng [5e7], however, the effects of American ginseng on CRC
therapeutics have not been evaluated.
Chronic inﬂammation is recognized as a risk factor for tumor
development, including CRC [8e10]. There is growing evidence to
support the efﬁcacy of natural products possessing anti-
inﬂammatory activities. Published studies suggested that ginseng
not only has cancer prevention potential [4,5,11,12], but also has
anti-inﬂammatory effects [13,14]. Various data suggest that ginseng
reduces inﬂammation and suppresses colitis by restoring gut ho-
meostasis [15e17], and this anti-inﬂammatory activity likely plays
a critical role in cancer prevention and treatment [18e20].
American ginseng (Panax quinquefolius L.) is one of the most
commonly used herbal medicines in the United States [21,22].
Similar to Asian ginseng, a signiﬁcant number of ginsenosides have
been identiﬁed in American ginseng. These ginsenosides fall into
two major groups: the protopanaxadiol group and the proto-
panaxatriol group, which differ in the presence of the carboxyl
group at the C-6 position [21,23]. However, the ginsenoside proﬁle
between American ginseng and Asian ginseng is different, and this
difference may contribute to their different pharmacological ef-
fects. Interestingly, American ginseng has approximately over
onefold higher ginsenoside content than Asian ginseng [21,24,25].
In addition to ginsenosides, ginseng also contains other bioactive
compounds [21,24].
Signiﬁcant antitumor effects of American ginseng were
observed in the CRC cell-xenografted nude mouse model [26,27].
However, the nude mouse is not a gut disease-speciﬁc animal
model. Thus, it is desirable to use speciﬁc gut inﬂammatory and
malignancy animal models. In this study, we used ApcMin/þmice, an
animal model with mutations in the Apc gene. This multiple in-
testinal neoplasia (Min) mouse is characterized by early lethality,
colon tumors, and development of a number of polyps in the small
intestine [28e30]. Our data demonstrated that American ginseng
signiﬁcantly reduced the progression of high-fat-diet-enhanced
carcinogenesis in this ApcMin/þmouse model.
2. Materials and methods
2.1. Chemicals and reagents
High-performance liquid chromatography (HPLC)-grade
ethanol, n-butanol, acetonitrile, and dimethyl sulfoxide were pur-
chased from Fisher Scientiﬁc (Pittsburgh, PA, USA). Milli-Q water
was supplied by a water puriﬁcation system (US Filter, Palm Desert,
CA, USA). Standards of ginsenosides Rb1, Rb2, Rb3, Rc, Rd, Re, Rf,
Rg1, Rg2, 20R-Rg2, Rg3, Rh1, and Rh2 were obtained from INDO-
FINE Chemical Company (Somerville, NJ, USA) or Delta Information
Center for Natural Organic Compounds (Xuancheng, Anhui, China).
All standards were of biochemical-reagent grade and at least 95%
pure. Other reagents were of biochemical-reagent grade.
2.2. Botanical material and preparation
The 4-year-old roots of American ginseng (P. quinquefolius L.)
were purchased from Roland Ginseng, LLC (Wausau, WI, USA). The
voucher samples were authenticated by C.-Z.W. and deposited at
the Tang Center for Herbal Medicine Research at the University of
Chicago (Chicago, IL, USA). The American ginseng extract wasprepared with a slight modiﬁcation from previous works [31e33].
The air-dried roots of American ginseng were pulverized into
powder form and sieved through an 80-mesh screen. One kilogram
of the powder was placed into a 12-L ﬂask and extracted three
times by heat reﬂux with 8 L of 75% (v/v) ethanol at 95C for 4 h
each time. The extracting solution was ﬁltered while hot. The
gathered and combined ﬁltratewas evaporated under vacuumwith
a Buchi rotary evaporator (Buchi Corporation, New Castle, DE, USA).
The obtained extract was dissolved in water, and then extracted
with water-saturated n-butanol. The n-butanol phase was evapo-
rated at 65C under vacuum and lyophilized.
2.3. Phytochemical analysis
The American ginseng extract was analyzed using HPLC [34,35].
The HPLC system used was a Waters Alliance 2960 instrument
(Milford, MA, USA) with a quaternary pump, an automatic injector,
a photodiode array detector (Model 996), and Waters Millennium
32 software for peak identiﬁcation and integration. The separation
was carried out on a Prodigy ODS2 column (250 mm  3.2 mm i.d.;
Phenomenex, Torrance, CA, USA) with a guard column (Prodigy,
3.0 mm  4.0 mm i.d.; Phenomenex).
For the HPLC analysis, a 20-mL sample was injected into the
column and eluted at room temperature with a constant ﬂow rate
of 1.0 mL/min. For the mobile phase, acetonitrile (Solvent A) and
water (Solvent B) were used. Gradient elution started with 17.5%
Solvent A and 82.5% Solvent B. Elution solvents were then changed
to 21% Solvent A for 20 min, then to 26% Solvent A for 3 min and
held for 19 min, maintained at 36% Solvent A for 13 min, at 50%
Solvent A for 9 min, at 95% Solvent A for 2 min and held for 3 min.
Finally, eluting solvents were changed to 17.5% Solvent A for 3 min
and held for 8 min. The detectionwavelength was set at 202 nm. All
sample solutions were ﬁltered through a membrane ﬁlter (0.2-mm
pore size). The content of the constituents was calculated using
standard curves of the ginsenosides. The contents of American
ginseng were measured in triplicate. Malonyl ginsenosides were
not measured in this investigation.
2.4. Animals and experimental protocol
The experimental protocols were approved by the Institutional
Animal Care and Use Committee of the University of Chicago. Male
C57BL/6J-ApcMin/J and female C57BL/6J mice were purchased from
Jackson Laboratory (Bar Harbor, ME, USA) for breeding. Mice were
caged under controlled room temperature, humidity, and light (12/
12-h light/dark cycle) and had free access to mouse chow and tap
water. After weaning, genotyping was carried out by tail biopsy
using PCR-based assays to identify ApcMin/þmice [28].
The study protocol is shown in Fig. 1. There were six animal
groups (n ¼ 6e9 animals/group). Prior to 6 wk of age, all mice
consumed standard mouse chow. The ApcMin/þ mice were ran-
domized at 6 wk of age and placed into the following experimental
groups: (1) mice that received Western high-fat diet were catego-
rized as the model group (M-HF); (2) mice that received standard
diet as the control group (M-SD); (3) mice that received Western
high-fat diet supplemented with 200 ppm of the American ginseng
extract, equivalent to 20 mg/kg/d, as the high-dose ginseng group
(M-GH); (4) mice that received Western high-fat diet supple-
mented with 100 ppm of the American ginseng extract, equivalent
to 10 mg/kg/d, as the low-dose ginseng group (M-GL). As the
control or negative control group, two wild-type mice groups were
used: (1) wild-type mice fed with standard diet (wild-type stan-
dard diet control group, or W-SD); (2) wild-type mice fed with
Western high-fat diet (wild-type high-fat-diet control group, or W-
HF). The Western diet (Harlan Laboratories, Madison, WI, USA)
Table 1
Primers used for RT-qPCR analysis of inﬂammatory cytokines
Gene Primer Sequence
IL1a Forward primer 50-CGAAGACTACAGTTCTGCCATT-30
Reverse primer 5e-GACGTTTCAGAGGTTCTCAGAG-3G
IL1b Forward primer 5o-GCAACTGTTCCTGAACTCAACT-3G
Reverse primer 5e-ATCTTTTGGGGTCCGTCAACT-3A
IL6 Forward primer 5o-TAGTCCTTCCTACCCCAATTTCC-3T
Reverse primer 5e-TTGGTCCTTAGCCACTCCTTC-3T
IFN-g Forward primer 5o-ATGAACGCTACACACTGCATC-3A
Reverse primer 5e-CCATCCTTTTGCCAGTTCCTC-3C
G-CSF Forward primer 5o-ATGGCTCAACTTTCTGCCCAG-3A
Reverse primer 5e-CTGACAGTGACCAGGGGAAC-3C
GM-CSF Forward primer 5o-GGCCTTGGAAGCATGTAGAGG-3G
Reverse primer 5e-GGAGAACTCGTTAGAGACGACTT-3G
b-actin Forward primer 5o-GGCTGTATTCCCCTCCATCG-3G
Reverse primer 5e-CCAGTTGGTAACAATGCCATGT-3C
RT-qPCR, quantitative real-time polymerase chain reaction
Fig. 1. Experimental groups and study time lines. Prior to the age of 6 wk, all mice
consumed standard mouse chow. The six experimental groups (n ¼ 6e9 animals/
group) are as follows: (1) M-HF, mice fed with Western high-fat diet as the model
group; (2) M-SD, mice fed with standard diet as the control group; (3) M-GH, mice fed
with Western diet supplemented with high-dose American ginseng extract; (4) M-GL,
mice fed with Western diet supplemented with low-dose American ginseng extract;
(5) W-SD, wild-type mice fed with standard diet; and (6) W-HF, wild-type mice fed
with Western high-fat diet. Study protocols are presented in the “Materials and
methods” section.
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and corn oil (80 g/kg) [36]. Body weight of the animals was ob-
tained at least once per wk. No signiﬁcant adverse events were
observed in the mice after the ginseng treatment.
At the end of each observation period, samples of small intestine
and colon were harvested, ﬂushed immediately with ice-cold
phosphate-buffered saline, and slit open longitudinally. Under a
dissection microscope, tumor numbers in the proximal, middle,
and distal ends of the small intestine and the colonwere counted by
two independent investigators who were blinded with respect to
the treatment group. Small intestinal and colon samples were ﬁxed
in 10% neutral-buffered formalin, embedded in parafﬁn blocks, and
processed by routine histological staining. Some colon tissue was
collected for quantitative real-time polymerase chain reaction
(qRT-PCR) analysis of interleukin-1a (IL-1a), IL-1b, IL-6, tumor ne-
crosis factor (TNF-a), granulocyte-colony stimulating factor (G-
CSF), and granulocyte-macrophage colony-stimulating factor (GM-
CSF).2.5. Histological assessment
Parafﬁn-embedded tissue samples were serially sectioned, and
some of these sections were stained with hematoxylin and eosin.
The stained sections were subsequently examined for histopatho-
logical changes by a gastrointestinal pathologist.2.6. RNA extraction and qRT-PCR
Total RNAwas isolated from the mouse colonic tissues using the
miRNeasy kit (Qiagen, Valencia, CA, USA) according to the manu-
facturer’s instructions and was used as a template to synthesize
complementary DNA for qRT-PCR. First-strand cDNA was synthe-
sized using Thermo Scientiﬁc Maxima ﬁrst-strand cDNA synthesis
kit. RT-qPCR was performed on a real-time PCR system (7900HT;
Applied Biosystems, Foster City, CA, USA). RT-qPCR with SYBR
Green dye (Qiagen) was used to determine the expression of genes.Primers for RT-qPCR are presented in Table 1. b actin was used as
the endogenous control. Each sample was run in triplicate.2.7. Statistical analysis
Data were presented as mean  standard deviation. Data were
analyzed using analysis of variance for repeated measures and
Student t test. All analyses were performed using SPSS version 14.0
(IBM Corporation, Somers, NY, USA). The level of statistical signif-
icance was set at p < 0.05.3. Results
3.1. Saponin composition in the study samples
Fig. 2A shows the chemical structures of ginsenosides in both
the protopanaxadiol and protopanaxatriol groups in the American
ginseng root. A typical HPLC chromatogram of the ginseng extract is
shown in Fig. 2B. The levels of the measured 11 ginsenosides are
presented in Fig. 2C. Themajor constituents of the protopanaxatriol
group are Re, followed by Rg1. More than 70% of the ginsenosides
are in the protopanaxadiol group, including Rb1, Rd, Rc, Rb3, and
Rb2. Unlike in Asian ginseng, no ginsenoside Rf was detected in
American ginseng.3.2. Body weight changes
The body weight changes of the animals in different experi-
mental groups are shown in Fig. 3. Wild-type mice with standard
diet had an approximate weight increase of 12 g over the 10-wk
observation period. As expected, those wild-type mice fed with
Western high-fat diet had an even higher weight increase of
approximately 17 g. However, the ApcMin/þmice in the model group
did not respond to the high-fat diet well, and their weight only
increased slightly. For the model group mice, the body weight
started to decrease fromWk 10, and all mice died on or prior to Wk
18. By contrast, the ApcMin/þ mice with standard diet had obvious
weight gain (w 13 g), suggesting that the high-fat diet effectively
caused some pathological changes in the ApcMin/þ mice. High-dose
American ginseng showed some small increase in body weight.
Interestingly, low-dose American ginseng perceptibly increased
body weight, suggesting the reduced pathological problems. The
low-dose American ginseng data were consistent with the gut
histology and tumor multiplicity data presented in the following
section.
Fig. 2. Major ginsenosides in American ginseng (Panax quinquefolius). (A) Chemical structures of ginsenosides in both the protopanaxadiol and protopanaxatriol groups. (B) A
representative high-performance liquid chromatography chromatogram of the American ginseng extract. (C) Levels of the measured 11 ginsenosides.
C. Yu et al / Ginseng and colon cancer 2333.3. Gut histopathology changes
Fig. 4 shows the representative hematoxylin and eosin staining
histological sections of experimental animals with different treat-
ments. Histological analysis of the tissues from the model group
showed prominent adenomatous change along with inﬂammatory
lesions, such as some neutrophil inﬁltration. Focal adenomatous
change can also be seen in the ApcMin/þ mice with standard diet.
However, in the ginseng-treated groups, especially the low-dose
ginseng group, the dysplastic changes were greatly reduced in
both small intestine and colon slides.
3.4. Tumor multiplicity changes
Compared with the high-fat diet, APCmin/þmice that received
standard diet had reduced tumor numbers. After treatment withAmerican ginseng, the tumor numbers were very signiﬁcantly
reduced in both the small intestine (including the proximal, middle,
and distal ends) and the colon (all p < 0.01). In addition, tumor
number reduction was more obvious in those mice treated with
low-dose American ginseng (Fig. 5).3.5. qRT-PCR analysis
Fig. 6 shows the qRT-PCR analysis of IL-1a, IL-1b, IL-6, TNF-a, G-
CSF, and GM-CSF levels in the tissue obtained from themodel group
and the American ginseng groups. The results of the analysis
indicated that low-dose American ginseng had better activities in
the small intestine. Only low-dose ginseng was used in colon
samples because this dose was more effective in the small intestine
(Figs. 6A, 6B).
Fig. 3. Changes in animal body weight. As discussed in the text, the ApcMin/þ mice
received low-dose American ginseng in this study, which appeared to have evident
therapeutic effects. The six experimental groups (n ¼ 6e9 animals/group) are as fol-
lows: (1) M-HF, mice fed with Western high-fat diet as the model group; (2) M-SD,
mice fed with standard diet as the control group; (3) M-GH, mice fed with Western
diet supplemented with high-dose American ginseng extract; (4) M-GL, mice fed with
Western diet supplemented with low-dose American ginseng extract; (5) W-SD, wild-
type mice fed with standard diet; and (6) W-HF, wild-type mice fed with Western
high-fat diet. Study protocols are presented in the “Materials and methods” section.
J Ginseng Res 2015;39:230e2372344. Discussion
Inﬂammatory bowel disease is a group of inﬂammatory condi-
tions in the large and small intestine in humans. Inﬂammation can
initiate and promote stimuli and mediators, generating a tumor-
prone microenvironment. Chronic inﬂammation is recognized as
a risk factor for tumor development, including CRC [8e10]. Tar-
geting inﬂammatory pathways has been shown to be effective in
preventing the formation of colon tumors and their malignant
progression in both animal and human studies [37]. The use ofFig. 4. Effects of American ginseng on the histological characterization in ApcMin/þ mice. Rep
changes in (A) the small intestine and (B) the colon with different treatments. The scale in th
The six experimental groups (n ¼ 6e9 animals/group) are as follows: (1) M-HF, mice fed with
control group; (3) M-GH, mice fed with Western diet supplemented with high-dose Americ
American ginseng extract; (5) W-SD, wild-type mice fed with standard diet; and (6) W-HF
“Materials and methods” section.nonsteroidal anti-inﬂammatory drugs (NSAIDs) can reduce CRC
tumorigenesis, but concerns and long-term risks of NSAIDs make
this form of prevention unsuitable as a general recommendation
[38,39]. Given the limitations of today’s clinical practice, there is a
strong motivation for exploring alternative strategies, including
using herbal medicines, in the management of malignancies in the
gastrointestinal system [40e43].
To evaluate the pharmacological effects on gut inﬂammation
and tumorigenesis, two gut-speciﬁc animal models have been used
in this study, namely, the AOM/DSS and ApcMin/þ mice. AOM/DSS is
a chemical-compound-induced model, characterized by early
inﬂammation followed by tumor development [44,45]. This
chemically induced murinemodel has been used for inﬂammation-
related colon carcinogenesis in the last decade. To further charac-
terize the activities of American ginseng, we used a genetically
engineered mouse model that has a mutation in the Apc gene
resulting in the growth of small intestine polyps and colon tumors
associated with inﬂammation [46,47]. The association of inﬂam-
mation with tumorigenesis in the ApcMin/þ mouse model has been
reported [46]. For example, celecoxib, a cyclooxygenase-2 inhibitor
that belongs to the NSAID family, has been reported to possess
potent preventive and therapeutic effects in ApcMin/þ mice [47].
In our study, we demonstrated that low oral dose of American
ginseng signiﬁcantly reduced the progression of high-fat-diet-
enhanced carcinogenesis in ApcMin/þ mice. qRT-PCR analysis data
showed that comparedwith themodel group, ginseng, especially at
low doses, very signiﬁcantly reduced the gene expression inﬂam-
mation cytokines, such as IL-1a, IL-1b, IL-6, TNF-a, G-CSF, and GM-
CSF in the tissue from both the small intestine and the colon. The
qRT-PCR results were consistent with survival, tumor growth in-
hibition, and histology data.
As with many other herbal medicines, American ginseng is
almost always taken orally. Unlike parenteral administration that
has been used in many animal studies, the enteric microbiome
likely plays an important role after the oral intake of ginseng
[29,36,37,48]. When ingested orally, the bioavailability of ginseng is
low due to incomplete absorption of parent compound and theresentative hematoxylin and eosin staining histological sections showing inﬂammatory
e low right ﬁgure is 200mM. Arrowheads indicate inﬂammation lesions in the gut tissue.
Western high-fat diet as the model group; (2) M-SD, mice fed with standard diet as the
an ginseng extract; (4) M-GL, mice fed with Western diet supplemented with low-dose
, wild-type mice fed with Western high-fat diet. Study protocols are presented in the
Fig. 5. Effects of American ginseng on gut carcinogenesis. (A) Macroscopic view of representative gut samples from the small intestine and the colon. (B) American ginseng
signiﬁcantly reduces the tumor numbers in the different gut segments. Tumors in the gut tissue are indicated by arrowheads (**p < 0.01 compared with the model group). The six
experimental groups (n¼ 6e9 animals/group) are as follows: (1) M-HF, mice fed with Western high-fat diet as the model group; (2) M-SD, mice fed with standard diet as the control
group; (3) M-GH, mice fed with Western diet supplemented with high-dose American ginseng extract; (4) M-GL, mice fed with Western diet supplemented with low-dose
American ginseng extract; (5) W-SD, wild-type mice fed with standard diet; and (6) W-HF, wild-type mice fed with Western high-fat diet. Study protocols are presented in the
“Materials and methods” section.
C. Yu et al / Ginseng and colon cancer 235conversion of parent ginsenosides to bioactive ginseng metabolites
by the enteric microbiome that involves a stepwise cleavage of
sugar moieties [33,49,50]. After ginseng ingestion, compound K
and protopanaxadiol are the major metabolites that reach systemic
circulation, and these metabolites likely possess signiﬁcant anti-
inﬂammatory and anticancer properties [26,51]. At the same
time, ginseng and its metabolites may alter the structure of the
enteric microbiome. The conversion of ginseng saponins by human
enteric microbiome was recently demonstrated, with > 20 me-
tabolites detected [33]. In our ongoing investigations, ginseng
metabolites in various biological samples (plasma, bile, urine, and
stool) are being analyzed using ultraperformance liquid chroma-
tography with quadruple time-of-ﬂight mass spectrometry. Inaddition to compound K and protopanaxadiol, other ginseng me-
tabolites should be searched, which may have even stronger bio-
activities [26,52]. Further, other compounds identiﬁed in ginseng,
such as polyacetylenes [24], are likely to have pharmacological
activities, and they should also be evaluated in future studies.
In summary, using a gut-speciﬁc inﬂammation and carcino-
genesis ApcMin/þmouse model, we reported that a low oral dose of
American ginseng signiﬁcantly reduced gut inﬂammation and tu-
mor initiation and progression. The observed effects were sup-
ported by the body weight change, gut tissue histology, and gut
inﬂammation cytokine data. Further studies are needed to link our
observed effects to the actions of the gut microbiome in converting
the parent ginsenosides to bioactive ginseng metabolites. Our data
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Fig. 6. Quantitative real-time polymerase chain reaction analysis of IL-1a, IL-1b, IL-6, IFN-g, G-CSF, and GM-CSF in the gut tissue from the model group and the American ginseng
groups. (A) Small intestine. (B) Colon. Only low-dose ginseng is used in colon samples because this dose is more effective in the small intestine. *p < 0.01 compared with the model
group. The six experimental groups (n ¼ 6e9 animals/group) are as follows: (1) M-HF, mice fed with Western high-fat diet as the model group; (2) M-SD, mice fed with standard
diet as the control group; (3) M-GH, mice fed with Western diet supplemented with high-dose American ginseng extract; (4) M-GL, mice fed with Western diet supplemented with
low-dose American ginseng extract; (5) W-SD, wild-type mice fed with standard diet; and (6) W-HF, wild-type mice fed with Western high-fat diet. Study protocols are presented in
the “Materials and methods” section. G-CSF, granulocyte-colony stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin.
J Ginseng Res 2015;39:230e237236suggest that American ginseng may have a therapeutic role in CRC
chemoprevention.
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